HIV virologic response better with single-tablet once daily regimens compared to multiple-tablet daily regimens
Background: Single-tablet regimens are preferred prescription choices for HIV treatment, but there are limited outcomes data comparing single-tablet regimens to multiple-tablet regimens. Methods: We retrospectively assessed treatment-naïve patients at a single urban HIV clinic in the United States f...
Main Authors: | Shashi N Kapadia, Robert R Grant, Susan B German, Baljinder Singh, Amy L Davidow, Shobha Swaminathan, Sally Hodder |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-12-01
|
Series: | SAGE Open Medicine |
Online Access: | https://doi.org/10.1177/2050312118816919 |
Similar Items
-
Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.
by: Laurent Cotte, et al.
Published: (2017-01-01) -
Once-daily dose regimen of ribavirin is interchangeable with a twice-daily dose regimen: randomized open clinical trial
by: Balk JM, et al.
Published: (2015-08-01) -
Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US
by: Juday T, et al.
Published: (2013-09-01) -
Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia
by: Irving GA, et al.
Published: (2012-06-01) -
Pharmacokinetic Variability of Amikacin After Once-Daily and Twice-Daily Dosing Regimen in Full-Term Neonates
by: Katarina Vučićević, et al.
Published: (2014-01-01)